This innovative method has the potential to unlock new treatment options for chronic conditions driven by mitochondrial dysregulation. HOUSTON, March 04, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc.

Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have ...

FibroBiologics (FBLG) announced the filing of a patent application with the United States Patent and Trademark Office covering methods ...

This innovative method has the potential to unlock new treatment options for chronic conditions driven by mitochondrial dysregulation. HOUSTON, March 04, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc.

Windtree Therapeutics (WINT) announced that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S. application ...

Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, ...

The US Patent and Trademark Office’s move to make it easier for administrative judges to turn away validity challenges swings ...

The Business Software Alliance said international alliances, export control regimes and standards harmonization efforts can ...

Some are using president Trump’s speech to highlight his administration's sweeping changes to the federal workforce.

Just like German automakers, Hyundai wants to sell the impression of performance for those who can't afford the real thing.

On February 28, 2025, the United States Patent and Trademark Office announced that it has rescinded the June 21, 2022, ...

Online vulnerabilities lead to the loss of U.S. intellectual property, which strikes the heart of our competitive advantage globally.